EverSource Wealth Advisors’s Amphastar Pharmaceuticals AMPH Stock Holding History

EverSource Wealth Advisors’s Portfolio AMPH Stock Details AMPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$470	Sell	24 -66	-73%	-$1.61K	﹤0.01%	4078
2025 Q4	$2.41K	Sell	90 -10	-10%	-$258	﹤0.01%	3429
2025 Q3	$2.67K	Sell	100 -159	-61%	-$4.11K	﹤0.01%	3417
2025 Q2	$5.95K	Buy	259 +255	+6,375%	+$6.33K	﹤0.01%	3082
2025 Q1	$116	Buy	4 +3	+300%	+$96	﹤0.01%	3806
2024 Q4	$37	Buy	+1	New	+$46	﹤0.01%	3661
2024 Q1	–	Sell	-60	Closed	-$3.71K	–	2900
2023 Q4	$3.71K	Buy	+60	New	+$3.15K	﹤0.01%	1977

Other funds holding AMPH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return

EverSource Wealth Advisors's AMPH Position: Q1 2026 in Review

EverSource Wealth Advisors reduced its Amphastar Pharmaceuticals (AMPH) stake by 73% in Q1 2026, selling an estimated $1.61K and leaving 24 shares worth $470. The position accounts for ﹤0.01% of the portfolio, ranked #4078.

EverSource Wealth Advisors first reported a position in AMPH in Q4 2023 and has held it in 7 quarters since. The position peaked at $5.95K in Q2 2025. 215 funds tracked by Wall St. Rank hold AMPH as of Q1 2026.

EverSource Wealth Advisors held 24 shares of Amphastar Pharmaceuticals worth $470 as of Q1 2026.
EverSource Wealth Advisors sold 66 Amphastar Pharmaceuticals shares in Q1 2026, an estimated $1.61K.
Amphastar Pharmaceuticals made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q1 2026, its #4078 holding.
EverSource Wealth Advisors first reported a position in Amphastar Pharmaceuticals in Q4 2023 and has held it in 7 quarters since.
EverSource Wealth Advisors's Amphastar Pharmaceuticals position peaked at $5.95K in Q2 2025.
215 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2026.

Based on EverSource Wealth Advisors's 13F filing for Q1 2026, filed 14 May 2026.